Hibernia Wealth Partners LLC Acquires 529 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hibernia Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1,102.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 577 shares of the healthcare conglomerate’s stock after purchasing an additional 529 shares during the quarter. Hibernia Wealth Partners LLC’s holdings in UnitedHealth Group were worth $304,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in UNH. Axiom Financial Strategies LLC bought a new position in UnitedHealth Group in the first quarter valued at approximately $210,000. McGowan Group Asset Management Inc. grew its stake in shares of UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after buying an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after buying an additional 60,300 shares during the last quarter. MAS Advisors LLC grew its stake in shares of UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after buying an additional 45 shares during the last quarter. Finally, First Western Trust Bank bought a new stake in shares of UnitedHealth Group during the first quarter worth $875,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.3 %

Shares of NYSE UNH traded up $1.60 during trading on Friday, hitting $494.70. 3,820,008 shares of the company traded hands, compared to its average volume of 4,274,309. The business’s fifty day moving average is $502.66 and its 200 day moving average is $518.44. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The firm has a market capitalization of $456.08 billion, a price-to-earnings ratio of 20.75, a P/E/G ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the prior year, the business earned $5.34 earnings per share. The business’s quarterly revenue was up 14.1% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 31.54%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on UNH. Truist Financial reaffirmed a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. Stephens reiterated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Barclays assumed coverage on shares of UnitedHealth Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target on the stock. Piper Sandler cut their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a report on Wednesday, January 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Friday, January 19th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $579.33.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.